Sponsored Content
Study: CGMs Show Promise in Early Diagnostic of Type 2 Diabetes
This method supports improved, early detection for diabetes without relying on blood samples or complex procedures.
Wicked Good Cardiometabolic Chat: Compounded Weight Loss Medications
In the first episode of the podcast, Jennifer Goldman and Hailey Choi discuss the latest FDA updates around compounded weight loss medications, clinical concerns and how pharmacists can protect their patients.
American Diabetes Association Issues Updates to Standards of Care in Diabetes for 2025
The authors emphasize the importance of multifaceted and team-based approaches to the management of diabetes.
The Pharmacist’s Role in Counseling Patients on GLP-1 Medications
With expertise in the management and treatment of diabetes, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, shared her insights on counseling patients using GLP-1 medications.
Inflammatory Biomarker Linked to Type 2 Diabetes Shows Increased Risk of Liver Cancer
Furthermore, C-reactive protein has greater prognosis for lung cancer, colorectal cancer, and ovarian cancer.
FDA Clears New Dexcom G7 15 Day Continuous Glucose Monitoring System
Pharmacists have positive impacts on health outcomes for diabetes and patients using CGM devices, including reductions in A1c.
